Duhay Francis
SEC Form 4 insider trading activity
Duhay Francis has filed 5 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Sep 14, 2026.
On the most recent filing, Duhay Francis is listed as Director at enVVeno Medical Corp. Inside the rolling window, Duhay Francis reported no open-market purchases and 4 open-market sales totaling $5K in NVNO. The largest disclosed transaction in the window is a sale of 4,900 NVNO shares on Dec 11, 2025, worth $2K.
Companies traded
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$5K
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Sep 15, 2025 | NVNO | Sale | $4K |
Frequently asked questions
How many SEC Form 4 filings has Duhay Francis made?
Duhay Francis has filed 5 SEC Form 4 filings (5 transaction rows) across 1 company since 2025.
Which companies does Duhay Francis trade?
Duhay Francis has filed SEC Form 4 disclosures for 1 company, including NVNO.
When was Duhay Francis's most recent SEC Form 4 filing?
Duhay Francis's most recent SEC Form 4 filing on Tracefour is dated Sep 14, 2026.
What is Duhay Francis's total buy and sell value in the current window?
Inside the rolling retention window, Duhay Francis bought $0 and sold $5K based on SEC Form 4 filings.
What was Duhay Francis's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 4,900 NVNO shares on 2025-12-11, worth $2K, per SEC Form 4 filings.